SRF Limited manufactures and sells chemical based industrial intermediates in India.
Twit about SRF stock
Latest twits on SRF (SRF)
Raks 02:59 PM 12-10-2016
$JUBILANT Jubilant Life Sciences recommended on 22nd Aug 2016 @ Rs 506.Now @ Rs 651 $BRITANNIA recommended in Aug 2015 @ Rs 2545. Now @ Rs 3375 $SRF recommended on 23rd Feb 2015 @ Rs 920. Now @ Rs 1896 $GMBREW from Rs.303 now Rs. 590 $LINCOLNPH from Rs 163 now Rs 233 #bullish#buy
$SRF Hit 52 week high of Rs.1556. Had recommended at Rs.920 in Feb 2015. $ZENSARTECH Hit 52 week high of Rs.1130. Had recommended at Rs.920 in Aug 2015. These 2 stocks along with all the other stocks in my portfolio have rewarded me well.$LINCOPH , $GMBREW , $PinconSpirit , $WELSPUNIND , $BRITANNIA , $AJANTPHARM .Will recommend 2 more new bullish stocks in coming days. Just waiting for a specific market news on those stocks for confirming. For all my other stocks #bullish#buy
$LINCOPH Lincoln Pharmaceuticals recommended 29 Oct 2015 @Rs.163, now Rs.290.$GMBREW GM Breweries recommended 29 July 2015 @ Rs.303.95,now Rs.1087.$ZENSARTECH recommended 17th Aug 2015 @ Rs.920, now Rs.1076. $WELSPUNIND (788-872).$BRITANNIA (2545-2902).$SRF (920-1317). I will be recommending few more new stocks later which will give such bull rallies this year. All the mentioned stocks are still #bullish#buy
$BRITANNIA has hit a 52 week high of Rs.3434 today.$AJANTPHARM has hit Rs.1711 but the others $SRF$PITTILAM$WELSPUNIND and $GMBREW have fallen due to sudden China's unexpected move to weaken its currency yuan which gives them an unfair advantage in world markets. Short term looks weak and one can exit if need money urgently or else can hold as long term prospects are still good, but big falls and rises can be expected now onwards mainly due to China move resulting in currency fluctuations.
Raks 04:49 AM 06-08-2015
$SRF@Aaarti Ambani See also my not small cap recommendations even before June 11th. See my post On 29th May I said #bullish on $AJANTPHARM$BRITANNIA and $SRF. Now Ajanta Pharma 1580 - 1684 (104 increase) ,Britannia 2545 - 3228 (683 increase),SRF 1101 - 1499 (398 increase).Today is SRF results day, Iam expecting good results but even if it falls I will keep adding more of $SRF which I recommended on 16th Feb at Rs.934.
Aaarti Ambani 12:50 AM 05-08-2015
$SRF$WELSPUNIND$PITTILAM$GMBREW@Raks, impressive forecasts. Though isn't that is partly due to SENSEX rally which is going on since June 11 and has high impact in small cap stocks?
Raks 04:43 PM 04-08-2015
$PITTILAM Today even my $PITTILAM recommendation made on 30th July has hit 52 week high of Rs.85.50 along with all my other recommendations today hit 52 week high again $GMBREW Rs.355.50 $WELSPUNIND Rs.963 and $SRF Rs.1472 Still lot of upside remaining in all these stocks. #buy#bullish
Raks 03:44 PM 30-07-2015
$PITTILAM Today all my previous recommendations have hit 52 week highs $GMBREW Rs.334.30. $WELSPUNIND Rs.900. $SRF Rs.1387. Now recommending one more stock Pitti Laminations $PITTILAM at current level of Rs.72.25.Visit their website and look at their products and clients, all engineering giants of the industry, you will know the growth potential of this stock #buy#bullish
Raks 04:17 PM 23-07-2015
$WELSPUNIND Who all followed my advice on $SRF to buy at Rs.920-940 levels have been well rewarded. Presently $SRF trading at Rs.1316. Now one more recommendation from me. $WELSPUNIND buy in large numbers at present levels of Rs.788 Huge upside potential #buy#bullish
$SRF consolidated Annual PAT surges 86 per cent at Rs.302.81 crores up from Rs.162.46 crores.Standalone yearly profit is Rs.307.70 crores up by 42 per cent from Rs.216.55 crore.consolidated EBIDTA at Rs.791 crore,up 45 per cent,consolidated net sales at Rs.4492 crore,up 13 per cent.With sales from almost all of its products increasing and giving good margins,this year will see SRF shares reaching new highs from present correction level of Rs.947.#buy
Aaarti Ambani 01:57 PM 23-04-2015
$SRF@Raks it turned out to be a good stock pick, thanks for pointing out to this opportunity
Sumita Raman 02:33 PM 22-04-2015
$SRF@Raks That's good and why do you think this information is not included in the stock price already? 15x EV/EBITDA is not cheap
Raks 05:07 AM 21-04-2015
$SRF @ Sumita.SRF is a leading chemical player in fluorine chemistry, catering to agrochemical and pharmaceutical companies.Fluorine-based chemicals hold high prospects since around one-fifth of all drugs sold globally use at least one fluorine substituent.Expect high margin chemical business to sustain leading to improvement in its revenue contribution from 24% in FY14 to 34% in FY17E. Acquired Global DuPont Dymel. I can write more but its better you visit their website. #buy
Sumita Raman 02:00 AM 21-04-2015
$SRF@Raks could you please tell us the reasons why you think it's a good investment and why the stock will continue to grow?
Raks 04:55 PM 20-04-2015
$SRF The best stock in my portfolio. Today BSE down 555 points and NSE down 150 points but SRF up by Rs.40 and easily crossed 1100 and hit a new 52 week high today of Rs.1122 before closing today at RS.1105.I have always been adding more and more of SRF stock. Any profit booking or correction will be a good opportunity for new investors to add as there is still lot of upside left in this SRF Ltd. stock. #buy
Raks 12:41 AM 20-04-2015
$SRF According to Edelweiss brokerage initiate the coverage with BUY and a target price of Rs 1325. "We expect SRF to report earnings CAGR of 28 per cent over FY15-17E. SRF is trading at attractive valuations at P/E of 14x FY16E and 11x FY17E earnings. We initiate the coverage with BUY and a target price of Rs 1325," it added. #buy
Raks 09:01 PM 19-04-2015
$SRF Informed on 31st March that SRF will break its 52 week high of Rs.1025 very soon. Hit new high of Rs.1089 on 7th April. Now trading at Rs.1065. Stock will move up above Rs.1100 now and hit new highs.I have been recommending this stock to all my friends right from Rs.900 levels and they have also made huge profits on their money invested. Still lot of upside remaining in this stock. #buy
Nikhil Mahadevia 11:30 AM 07-04-2015
$SRF SRF Ltd informed BSE that Phase I of its Chemical Complex in Dahej, Gujarat has begun production of first batch of the product (P17A). The cost of the Phase I of the project is Rs. 63 Crore, while the overall cost is around Rs. 113 crore. www.indiainfoline.com/art...3_1.html
Dalip Malhan 11:38 PM 06-04-2015
$SRF for me after all the growth at current multiples the stock looks fairly priced. New production plants will take 6 months to have an impact on P&L #hold
Raks 05:03 PM 31-03-2015
$SRF Yesterday SRF up by Rs.60 and today up by Rs.40. Now trading at Rs.992. Stock will break its 52 week high of Rs.1025 very soon.They have started Phase 1 production in 2 new chemical plants on Mar 27th.Sales and volume growth to grow along with Net Profit. #Buy
Neha Krishnan 03:04 PM 23-02-2015
$SRF@Aaarti-Ambani 9x may be cheap if you assume that revneue grows 17% in 2016FY and EBITDA margin expands from 20% to 21% which is +5% to absolute EBITDA number
Raks 12:38 AM 23-02-2015
$SRF Its consolidating very well at present levels of 920-940 after hitting a 52 week high of 1025 on 4th Feb.The upmove will continue. Very good level to enter now at around 920. #buy
Rajesh Khattar 05:13 PM 16-02-2015
$SRF Q3 was disappointing for revenue and below expectation for EBITDA growth.
Net sales of SRF during the third quarter of 2014-15 increased marginally to Rs. 870.22
crore against Rs. 859.44 crore during CPLY in spite of reduction in commodity prices.
EBIDTA for the quarter is at Rs. 169.38 crore, a growth of 13% as compared to CPLY (Corresponding Period Last Year)
$SRF 14x EV/EBITDA 2014FY. 60% forecasted EBITDA growth in 2015FY will lead to 9x EV/EBITDA in May when 2015FY results are announced. 9x doesn't sound cheap.
Raks 04:14 AM 16-02-2015
$SRF.BUY.Profit of just 3 months is already 248.94 crores,and has already passed the full 4 months yearly Net Profit of FY 2013-14 (216 crores)by 14 per cent.Full year Net Profit would be above 301 crores which is a 40 per cent growth in Net Profit Year on Year.DuPont business will consolidate their market leadership. The access to the pharma segment allows SRF to move up the value chain and cater to the growing demand for the pharma grade HFC 134a.SRF is the only Indian supplier of the product.
SRF Limited manufactures and sells chemical based industrial intermediates in India. It operates in Technical Textiles Business, Chemicals and Polymers Business, and Packaging Films Business segments. The company